文献速递临床试验与 GCP

胸科手术单肺通气期间高与低呼气末正压的保护性通气(PROTHOR):随机对照试验研究方案

Protective ventilation with high versus low positive end-expiratory pressure during one-lung ventilation for thoracic surgery (PROTHOR): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-04-11

PROTHOR是一项由PROtective VEntilation NETwork研究者发起的国际多中心、随机对照、评估者盲法、双臂试验,计划纳入2378例18岁及以上、拟行开放胸科手术或视频辅助胸腔镜手术且需单肺通气的患者。患者随机接受呼气末正压10 cmH2O联合肺复张操作或呼气末正压5 cmH2O不联合肺复张操作,主要终点为术后肺部并发症复合终点。

要点

  • PROTHOR为国际多中心随机对照评估者盲法双臂试验,计划纳入2378例需单肺通气的胸科手术患者。
  • 干预组为呼气末正压10 cmH2O联合肺复张操作,对照组为呼气末正压5 cmH2O不联合肺复张操作。
  • 主要终点为术后肺部并发症的复合终点,试验注册号NCT02963025,注册日期2016年11月15日。

核心结论

  • PROTHOR是首个在胸科手术单肺通气患者中充分把握度比较术中高呼气末正压联合肺复张操作与低呼气末正压不联合肺复张操作对术后肺部并发症影响的随机对照试验。
  • PROTHOR试验结果将支持麻醉科医生在胸科手术单肺通气保护性通气中决定术中呼气末正压的设置。

研究设计与样本

  • PROTHOR为国际多中心、随机对照、评估者盲法、双臂试验,由PROtective VEntilation NETwork的研究者发起。
  • 计划随机分配2378例患者至两种术中机械通气策略之一。
  • 纳入标准为年龄18岁及以上、拟在全身麻醉下接受开放胸科手术或视频辅助胸腔镜手术且需要单肺通气、体重指数最大35 kg/m2、计划手术时长超过60分钟。
  • 进一步要求预期单肺通气时长长于双肺通气,并计划使用双腔管进行肺隔离。

主要发现

  • 患者随机接受呼气末正压10 cmH2O联合肺复张操作,或呼气末正压5 cmH2O不联合肺复张操作。
  • 双肺通气期间潮气量设为7 mL/kg预测体重,单肺通气期间降至5 mL/kg。
  • 主要终点为术后肺部并发症的发生,记录为单个不良肺部事件的折叠复合终点。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative pulmonary complications (PPC) may result in longer duration of in-hospital stay and even mortality. Both thoracic surgery and intraoperative mechanical ventilation settings add considerably to the risk of PPC. It is unclear if one-lung ventilation (OLV) for thoracic surgery with a strategy of intraoperative high positive end-expiratory pressure (PEEP) and recruitment maneuvers (RM) reduces PPC, compared to low PEEP without RM. METHODS: PROTHOR is an international, multicenter, randomized, controlled, assessor-blinded, two-arm trial initiated by investigators of the PROtective VEntilation NETwork. In total, 2378 patients will be randomly assigned to one of two different intraoperative mechanical ventilation strategies. Investigators screen patients aged 18 years or older, scheduled for open thoracic or video-assisted thoracoscopic surgery under general anesthesia requiring OLV, with a maximal body mass index of 35 kg/m2, and a planned duration of surgery of more than 60 min. Further, the expected duration of OLV shall be longer than two-lung ventilation, and lung separation is planned with a double lumen tube. Patients will be randomly assigned to PEEP of 10 cmH2O with lung RM, or PEEP of 5 cmH2O without RM. During two-lung ventilation tidal volume is set at 7 mL/kg predicted body weight and, during OLV, it will be decreased to 5 mL/kg. The occurrence of PPC will be recorded as a collapsed composite of single adverse pulmonary events and represents the primary endpoint. DISCUSSION: PROTHOR is the first randomized controlled trial in patients undergoing thoracic surgery with OLV that is adequately powered to compare the effects of intraoperative high PEEP with RM versus low PEEP without RM on PPC. The results of the PROTHOR trial will support anesthesiologists in their decision to set intraoperative PEEP during protective ventilation for OLV in thoracic surgery. TRIAL REGISTRATION: The trial was registered in clinicaltrials.gov ( NCT02963025 ) on 15 November 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kiss T, Wittenstein J, Becker C, et al. Protective ventilation with high versus low positive end-expiratory pressure during one-lung ventilation for thoracic surgery (PROTHOR): study protocol for a randomized controlled trial. Trials. 2019. PMID: 30975217. doi:10.1186/s13063-019-3208-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。